- For women who are severely obese (body mass index [BMI], >40) diet hardly ever produces long-term weight loss.
- When these patients are planning pregnancy, laparoscopic gastric banding offers more flexibility in adjusting the size of the gastric pouch than Roux-en-Y surgery.
For the past 30 years, I resolutely advised my severely obese patients to diet, exercise, and take the weight loss medications—metformin, sibutramine, orlistat—that I prescribed. I enlisted the aid of nutritionists, exercise trainers, counselors, endocrinologists, and general internists. But, except for the rare success, my approach was a miserable failure.
I was disappointed that most of my severely obese patients stayed that way.
Recently, however, I took a new direction in managing obese patients, and now I’m filled with optimism and hope. I routinely refer my patients whose BMI is >40 to a bariatric surgery center. Their success with weight loss after bariatric surgery has been remarkable.
Let us know!
Click here to submit a letter to the editor
Surgery isn’t undertaken lightly or quickly
In the surgical program with which I work, an eligible patient must spend 6 months in a nutrition and exercise program supervised by the bariatric surgery center before she is eligible for surgery. During that time, she is evaluated exhaustively for any nutritional, metabolic, and psychological issues that might interfere with the success of surgery or make surgery too risky. She receives extended counseling and discusses, in detail, risks and benefits of the surgery. The program works with her health insurance company to justify the planned surgery.
After surgery, the bariatric center builds on its established relationship with the patient by monitoring response to therapy and screening for nutritional deficiencies.
I am impressed with the results: Bariatric surgery is remarkably effective in helping my patients shed 25% to 50% of body weight. I’ve concluded that bariatric surgery is the gold standard for treating weight loss in severely obese women.
Many studies report the superiority of bariatric surgery over lifestyle interventions for severe obesity.
Confirmation from Sweden
In the Swedish Obese Subjects (SOS) Trial, men with a BMI of >34 and women with a BMI of >38 were offered bariatric surgery (gastric banding, gastroplasty, or gastric bypass; n=2,010) or standard medical and behavioral therapy (n=2,037). The study was initiated in 1987, with substantial long-term follow-up of subjects. Mean age of subjects was 48 years; mean BMI was 41.
Two years after entry, subjects’ weight had increased by a mean of 0.1% in the medical-behavioral therapy group and had decreased by a mean of 23% in the bariatric surgery group. Among the 1,703 subjects available for analysis 10 years after entry, weight had increased by a mean of 1.6% in the medical-behavioral therapy group and had decreased by a mean of 16% in the bariatric surgery group.1
The surgery group demonstrated greater improvement than the medical-behavioral therapy group in blood glucose and blood pressure control and had a greater increase in the serum level of high-density lipoprotein-C and a greater decrease in serum uric acid. The surgery group also reported an increase in the quality of life compared with the medical-behavioral group.2
Death rate is an important outcome. In the SOS trial, the surgery group had 24% fewer deaths than the behavioral-medical therapy group.3 In another large cohort study from the United States, the death rate among 7,925 patients who had undergone bariatric surgery was compared with the death rate among 7,925 control patients who were matched for age, sex, and BMI.4 Over 7.1 years of follow-up, the death rate was 40% lower in the surgical group than among controls. Death from diabetes was reduced by 92% and death from coronary artery disease was reduced by 56% in the surgery group.
Value in diabetes, too
Randomized clinical trials also support the use of bariatric surgery for obese patients who have diabetes. In one study, 60 patients with diabetes and obesity (BMI, 30 to 40) were randomized to gastric banding or conventional diabetes therapy, including weight loss and antihyperglycemia medications.
Remission of diabetes was achieved by 73% of subjects in the surgery group and by 13% of subjects in the medical-behavioral therapy group. Surgical patients lost 21% of body mass; medical-behavioral patients, 1.7% of body mass. Remission correlated highly with magnitude of weight loss.5
Meta-analysis is supportive
Examination of more than 140 studies of bariatric surgery concluded that there was substantial evidence of benefit from bariatric surgery in obese subjects with a BMI of >40.6